Singleject Trademark Details

Singleject was registered on Tuesday, August 1, 2000 and is currently owned by Amgen Inc. under the registration number 2373083 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 13 years ago on Friday, June 4, 2010, according to the United State Patent & Trademark Office
Word Mark Singleject
Status Alive Registered 800 — Registered and Renewed

Current Owner

Amgen Inc. of Newbury Park, CA

View all trademarks for Amgen Inc.
Other Trademarks for Amgen Inc.
Serial Number 74663645
Registration Number 2373083
Status Date Friday, June 4, 2010
Filing Date Friday, June 4, 2010
Registration Date Tuesday, August 1, 2000
Attorney Mark I. Feldman, Christina L. Martini

Correspondent

Mark I. Feldman, Christina L. Martini
DLA Piper LLP (US)
PO BOX 64807
CHICAGO IL 60664-0807

Case File Statements

Goods & Services Pharmaceutical Preparation Sold in Prefilled Syringes for Use in Connection with One or More of the Following - the Treatment of Viral, Neoplastic and Autoimmune Diseases; Treatment of Neurological Disorders; for Stimulating White Blood Cell Production; for Stimulating Red Blood Cell Production; and for Increasing Platelet Count
Pseudo Mark Single Eject

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Wednesday, August 4, 1999
First Use Anywhere Tuesday, February 16, 1999
First Use In Commerce Tuesday, February 16, 1999
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.